triptonide has been researched along with Cancer of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, M; Qi, J; Qiao, Y; Tan, S; Wang, X; Zhang, B; Zhang, M; Zhang, T; Zhao, Z; Zhou, Q | 1 |
| Cao, Z; Lv, C; Tan, S; Yu, D; Zhang, B; Zhang, M; Zhang, P; Zhao, Z; Zhou, Q | 1 |
2 other study(ies) available for triptonide and Cancer of Lung
| Article | Year |
|---|---|
Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis.
Topics: Animals; Cell Cycle Proteins; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Hippo Signaling Pathway; Humans; Lung Neoplasms; Melanoma; Mice; Mice, Nude; Protein Serine-Threonine Kinases; Triterpenes; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2021 |
Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Female; Hedgehog Proteins; Humans; Lung Neoplasms; Mice, Nude; Neoplastic Stem Cells; Patched-1 Receptor; Phenotype; Signal Transduction; Triterpenes; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2019 |